IBANDZONIC 150: Reliable Osteoporosis Prevention

IBANDZONIC 150

Ibandronate Sodium (150mg)

IBANDZONIC 150 combination of Ibandronate Sodium (150mg) is a potent bisphosphonate medication used primarily to treat and prevent osteoporosis in postmenopausal women. This medication helps increase bone mass and reduce the risk of fractures by inhibiting bone resorption.

What is Ibandronate Sodium (150mg)?

Ibandronate Sodium is a bisphosphonate that works by slowing down bone loss while increasing bone density, thereby preventing fractures.

• Primary Uses

  • Treatment of osteoporosis in postmenopausal women.
  • Prevention of bone fractures in individuals with weakened bones.
  • Occasionally used for other conditions involving bone loss.

• Key Benefits

  • Increases bone mineral density.
  • Improves overall bone health and strength.

• Dosage and Administration

  • Typically taken once a month, orally.
  • Remain upright for at least 60 minutes after taking the medication to prevent esophageal irritation.

• Possible Side Effects

  • Common: Abdominal pain, indigestion, flu-like symptoms.
  • Serious: Esophageal ulcers, severe bone, joint, or muscle pain, allergic reactions (rare).

How Does Ibandronate Sodium Work?

Ibandronate Sodium works by inhibiting osteoclast-mediated bone resorption, which helps in maintaining or increasing bone density.

• Mechanism of Action

  • Binds to hydroxyapatite in bone, inhibiting osteoclast activity.
  • Reduces bone turnover and bone loss.

• Effectiveness

  • Clinically proven to reduce fracture risk in postmenopausal women with osteoporosis.
  • Increases bone mineral density, particularly in the spine and hip.
  • Long-term benefits include sustained improvements in bone health.

IBANDZONIC 150:

A Reliable Solution for Osteoporosis IBANDZONIC 150 provides an effective treatment for postmenopausal osteoporosis, helping to maintain bone health and prevent fractures.

• Enhanced Benefits

  • Once-monthly dosing improves patient adherence.
  • Convenient and easy-to-follow regimen.
  • Effective in both treatment and prevention of osteoporosis-related fractures.

• Precautions

  • Ensure adequate intake of calcium and vitamin D during treatment.
  • Regular bone density tests may be recommended to monitor effectiveness.

Conclusion:

IBANDZONIC 150, containing Ibandronate Sodium (150mg), is an effective and convenient option for treating and preventing osteoporosis in postmenopausal women. Always consult your healthcare provider to ensure that IBANDZONIC 150 is the right choice for your osteoporosis treatment plan.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW